⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IONS News
Ionis Pharmaceuticals, Inc. Common Stock
IONS Investor Alert: Levi & Korsinsky Investigates Ionis Pharmaceuticals, Inc. (IONS) for Potential Securities Fraud
accessnewswire.com
IONS
Oligonucleotide CDMO Market to Reach USD 9.87 Billion by 2031 as RNA-Targeted Drug Pipelines Expand
globenewswire.com
A
BC
IONS
ALNY
ARWR
TMO
AMGN
DHR
LRCX
MRK
MLSS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS
globenewswire.com
IONS
IONS SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Ionis Pharmaceuticals, Inc. For Possible Securities Law Violations
accessnewswire.com
IONS
IONS Investor Alert: Levi & Korsinsky Investigates Ionis Pharmaceuticals, Inc. (IONS) for Potential Securities Fraud
accessnewswire.com
IONS
Ionis Pharmaceuticals, Inc. (IONS) Faces Investor Scrutiny After Surprise Trial Failure Drives Stock Down 23% – HBSS
globenewswire.com
IONS
Levi & Korsinsky Notifies Investors of a Pending Investigation Into Securities Claims Involving Ionis Pharmaceuticals (IONS)
globenewswire.com
IONS
Ionis Partner Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease
businesswire.com
IONS
IONS SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Ionis Pharmaceuticals, Inc. For Possible Securities Law Violations
accessnewswire.com
IONS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS
accessnewswire.com
IONS